In this episode, Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center, shares progress in pediatric leukemia and sickle cell disease treatments, the impact of a 30-year partnership with Aflac, and breakthroughs in precision medicine, CAR T-cell therapy, and gene therapy that are reshaping outcomes for children and families.
Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center
Advertisement
Advertisement
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Dr. David Klein, Partner and MD, Kennedy-White Orthopaedic Center, discusses how AI is improving scheduling, documentation, and…
-
In this episode, Robert Stone, Chief Executive Officer, Helen and Morgan Chu Chief Executive Officer Distinguished Chair, City of Hope,…
-
Josh Orzel on Building the Next Generation of Nursing Leaders and Supporting the Frontline Workforce
In this episode, Josh Orzel, Chief Nursing Officer, Saline Health System, discusses strengthening nursing culture, developing talent pipelines and supporting…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
Advertisement
Comments are closed.